Respiratory Morbidity
11
4
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates.
Respiratory Trends During Blood Transfusions in Newborns.
Mouthpiece With Integrated Cheek Support vs. Manual Cheek Support During Respiratory Oscillometry
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Low Dose Antenatal Corticosteroids for Late Preterm Delivery
Inhaled Furosemide for Transient Tachypnea of Newborn
Effect of Single Dose Antenatal Betamethasone on Neonatal Respiratory Morbidity After Elective Cesarean
The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants
Continuous Fascia Iliaca Block for Acute Hip Fractures
Dexmedetomidine Sedation in Children With Respiratory Morbidities
Effects and Costs of Respiratory Muscle Training in Institutionalized Elderly People